Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8116017rdf:typepubmed:Citationlld:pubmed
pubmed-article:8116017lifeskim:mentionsumls-concept:C0020538lld:lifeskim
pubmed-article:8116017lifeskim:mentionsumls-concept:C0051133lld:lifeskim
pubmed-article:8116017lifeskim:mentionsumls-concept:C0851285lld:lifeskim
pubmed-article:8116017pubmed:issue12lld:pubmed
pubmed-article:8116017pubmed:dateCreated1994-3-25lld:pubmed
pubmed-article:8116017pubmed:abstractTextMean mineralocorticoid receptor number in mononuclear leukocytes of patients with increased plasma aldosterone (Conn's syndrome, nephrovascular hypertension, preeclampsia) is lower than in controls and this reduction could be the consequence of a down-regulation of the receptor. A similar pattern is evident also in situations of excess of other mineralocorticoids (Cushing's syndrome, chronic licorice ingestion). In essential hypertension 20% of cases have reduced number of mineralocorticoid receptors in mononuclear leukocytes without increase of aldosterone and normal serum potassium. We postulate that in some cases with essential hypertension the reduction of mineralocorticoid receptors is an index of mineralocorticoid excess due to mineralocorticoids other than aldosterone.lld:pubmed
pubmed-article:8116017pubmed:languageenglld:pubmed
pubmed-article:8116017pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8116017pubmed:citationSubsetIMlld:pubmed
pubmed-article:8116017pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8116017pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8116017pubmed:statusMEDLINElld:pubmed
pubmed-article:8116017pubmed:monthDeclld:pubmed
pubmed-article:8116017pubmed:issn0039-128Xlld:pubmed
pubmed-article:8116017pubmed:authorpubmed-author:ArmaniniDDlld:pubmed
pubmed-article:8116017pubmed:authorpubmed-author:PratesiCClld:pubmed
pubmed-article:8116017pubmed:authorpubmed-author:ScalaEElld:pubmed
pubmed-article:8116017pubmed:authorpubmed-author:MartelliDDlld:pubmed
pubmed-article:8116017pubmed:authorpubmed-author:ZennaroC MCMlld:pubmed
pubmed-article:8116017pubmed:authorpubmed-author:ZampolloVVlld:pubmed
pubmed-article:8116017pubmed:issnTypePrintlld:pubmed
pubmed-article:8116017pubmed:volume58lld:pubmed
pubmed-article:8116017pubmed:ownerNLMlld:pubmed
pubmed-article:8116017pubmed:authorsCompleteYlld:pubmed
pubmed-article:8116017pubmed:pagination611-3lld:pubmed
pubmed-article:8116017pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:8116017pubmed:meshHeadingpubmed-meshheading:8116017-...lld:pubmed
pubmed-article:8116017pubmed:meshHeadingpubmed-meshheading:8116017-...lld:pubmed
pubmed-article:8116017pubmed:meshHeadingpubmed-meshheading:8116017-...lld:pubmed
pubmed-article:8116017pubmed:meshHeadingpubmed-meshheading:8116017-...lld:pubmed
pubmed-article:8116017pubmed:meshHeadingpubmed-meshheading:8116017-...lld:pubmed
pubmed-article:8116017pubmed:meshHeadingpubmed-meshheading:8116017-...lld:pubmed
pubmed-article:8116017pubmed:meshHeadingpubmed-meshheading:8116017-...lld:pubmed
pubmed-article:8116017pubmed:meshHeadingpubmed-meshheading:8116017-...lld:pubmed
pubmed-article:8116017pubmed:meshHeadingpubmed-meshheading:8116017-...lld:pubmed
pubmed-article:8116017pubmed:meshHeadingpubmed-meshheading:8116017-...lld:pubmed
pubmed-article:8116017pubmed:meshHeadingpubmed-meshheading:8116017-...lld:pubmed
pubmed-article:8116017pubmed:meshHeadingpubmed-meshheading:8116017-...lld:pubmed
pubmed-article:8116017pubmed:meshHeadingpubmed-meshheading:8116017-...lld:pubmed
pubmed-article:8116017pubmed:meshHeadingpubmed-meshheading:8116017-...lld:pubmed
pubmed-article:8116017pubmed:year1993lld:pubmed
pubmed-article:8116017pubmed:articleTitleRegulation of aldosterone receptors in hypertension.lld:pubmed
pubmed-article:8116017pubmed:affiliationIstituto Semeiotica Medica, University of Padua, Italy.lld:pubmed
pubmed-article:8116017pubmed:publicationTypeJournal Articlelld:pubmed